EN IT

AbbVie stock slips 3.0%, while the buy signal trade, in its management phase in week 25, is still 31.45% up since entry. Our model's coverage is complete, only the residual capital carries on, and the signal still reads as a medium expected move.

AbbVie -3.0%: turned back at its all-time high, trade still up 31.45%
Buy signal in week 25, model coverage complete

AbbVie -3.0%: turned back at its all-time high, trade still up 31.45%

November 20, 2026

Our view last week

AbbVie stock gains 1.3% and the buy signal is now in week 24, with the trade in its management phase and 35.51% up since entry. Our model's coverage is complete: the references were all hit in the early weeks, and only the residual capital is still in play. We see an orderly picture, and the remaining position can keep working under the discipline chosen at the outset.

This week's summary

AbbVie stock slips 3.0% on the week, turned back once more by its all-time high, the second time in the last 10 weeks. The buy signal, now in week 25, is in its management phase at 31.45% up since entry, and our model still sees a medium expected move behind it. The model's coverage is complete: all three reference points have already been hit, and only the residual capital stays in play.
Disclaimer. Technical analysis and personal opinion of the author, not financial advice or a personalised recommendation. The author may hold positions in the instruments analysed. Read more ▾Close ▴
Disclaimer — The content on this page is published for educational and informational purposes and represents the author's personal opinion and technical analysis. It is not financial advice, a solicitation to invest, or personalised recommendation. Trading financial instruments involves significant risks and may result in the loss of all or part of the invested capital. Every operational decision is the sole responsibility of the user, who acknowledges acting in full autonomy and full awareness of risk. The author may hold, open or close positions in the instruments analysed, including positions opposite to the analysis, before or after publication, with no obligation to disclose them.
Become a Platinum client to read the full technical analysis, the trading plan and the detailed entry, take-profit and stop-loss levels. 15-day free trial. ★ PLATINUM
restricted Platinum content
Share WhatsApp Telegram Gmail LinkedIn